Course of psychiatric symptoms and global cognition in early Parkinson disease.
about
Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.Tracking Parkinson's: Study Design and Baseline Patient Data.The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic reviewPotential sex differences in nonmotor symptoms in early drug-naive Parkinson diseaseThe impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in TaiwanParkinson's disease-related fatigue: A case definition and recommendations for clinical research.Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.Neuropsychiatric symptoms in untreated Parkinson's disease.Are sleep disturbances preclinical markers of Parkinson's disease?The role of neurotransmitters in the development of Parkinson's disease-related psychosis.Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study.Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.The psychosis spectrum in Parkinson disease.Emotional manifestations of PD: Neurobiological basis.A practical approach to detection and treatment of depression in Parkinson disease and dementia.Psychosis in parkinsonism: an unorthodox approach.Trajectories of prediagnostic functioning in Parkinson's disease.Hospital care for mental health and substance abuse conditions in Parkinson's disease.Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.Olfactory Dysfunction Evaluation Is Not Affected by Comorbid Depression in Parkinson's Disease.Application of texture analysis to DAT SPECT imaging: Relationship to clinical assessments.Cognitive and behavioral disorders in Parkinson's disease: an update. II: behavioral disorders.The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.The effect of unilateral subthalamic nucleus deep brain stimulation on depression in Parkinson's disease.Cognitive and Neuropsychiatric Features of Early Parkinson's Disease.Clinical predictors of cognitive impairment and psychiatric complications in Parkinson's disease.Parkinson's disease psychosis: presentation, diagnosis and management.Typical features of Parkinson disease and diagnostic challenges with microdeletion 22q11.2.CSF Aβ level is associated with cognitive decline in early Parkinson's disease with rapid eye movement sleep behavior disorderClinical Predictors of Excessive Daytime Sleepiness in Patients with Parkinson's Disease
P2860
Q27002626-112BB1FF-EED1-4097-BAAE-C92AA99B3B51Q30249553-8CB6F594-788B-440B-8295-AB97AB80CD2BQ31008758-B5C254A0-C2FE-4B91-9879-41094F4C49A6Q33917211-284B30FC-FC32-450F-A18A-C0EAA79E4198Q35671020-6866B733-6F7D-4A63-9CE7-BEFCD8D06F0EQ36284387-87E32A45-1763-4BD2-99A9-9DBA40434691Q36890229-C2634009-2D75-42CB-A325-437C49427F17Q37272851-0DC72055-7F12-4785-A97A-5FCB1C796B96Q37714081-799A93CC-970D-421D-BDFD-EB5ED188DA13Q38272658-D0C9C7C3-76EA-4EEC-B21E-69D135F5C7E4Q38649501-28F3F369-0EE3-42D1-BC71-5E9361336E8BQ38677697-F650C90C-49FD-4CBC-A6F4-32C648711BDAQ38743255-AA2BB9C9-404B-458E-9856-93846EACA1A8Q38768169-2A31467B-DCC0-4857-930C-0B67A74821F1Q38797335-8F2A320C-DD46-4E0E-8CE7-B315A3A2BFF0Q39242006-F4C42BA2-C6B7-4E3D-9735-C0B98AFC64F6Q39335522-C2F54BDF-261F-4BB0-BF92-92840FDDF602Q40383022-2B40AE75-605B-4B2F-B81E-562A9A92A7FEQ40429065-0AA3A9AE-B19D-4CD5-AD87-200CCB22E0A1Q40499334-3257352E-2F87-4557-AD47-4D4E10887328Q40930752-9AF4F024-5991-472B-963D-BB9B75CEBC5FQ41652414-BE9C3A1F-3CEE-44F2-B98D-CA724008765CQ42353561-E53A109C-F0A2-44A0-A300-68DACF7DBA4FQ47290343-E571B322-A4CA-45D7-ADD6-B27EA5DAAF73Q47400257-530EFE03-DA46-4D37-8EA5-2D0ADC5ED2F6Q47593272-5A2545D1-EA9C-4DF8-B52D-83E7DC4FB094Q48566146-4FE2C346-3FC8-4D50-85EF-3615806394DDQ50584508-188EA9B6-3776-4344-B744-A6C366ED7D96Q51781286-9CEAFCEA-192D-4958-B516-FF3ABE96DC32Q55110763-33AC40AF-F4CD-4A51-90F9-398FD30C2362Q58580982-AEF5DC99-3DEC-4650-8FE3-E2C0A345B787Q58760662-BA0713A0-DCAF-4E67-88CF-348D79E3E3AA
P2860
Course of psychiatric symptoms and global cognition in early Parkinson disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@ast
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@en
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@nl
type
label
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@ast
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@en
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@nl
prefLabel
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@ast
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@en
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@nl
P2093
P2860
P1433
P1476
Course of psychiatric symptoms and global cognition in early Parkinson disease.
@en
P2093
Kara Smith
Patricia de la Riva
Sharon X Xie
P2860
P304
P356
10.1212/WNL.0000000000000801
P407
P577
2014-08-15T00:00:00Z